NEKTAR THERAPEUTICS (NKTR)
Nektar to Hold Conference Call to Discuss 52-Week Topline Results from the 16-Week Extension Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on April 20, 2026
MOLECULAR PARTNERS AG (MOLN)
Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712
Y.D. MORE INVESTMENTS LTD (MRIN)
Holdings of interested parties/officers as of 31.3.26
BLUE SQUARE REAL ESTATE LTD (BLSR)
Events and transactions
CELLCOM ISRAEL LTD. (CEL)
Holdings of interested parties/officers as of 31.3.26
BLUE SQUARE REAL ESTATE LTD (BLSR)
Holdings of interested parties/officers as of 31.3.26
INROM CONSTRUCTION INDUSTRIES LTD (INRM)
Holdings of interested parties/officers as of 31.3.26
PAZ RETAIL AND ENERGY LTD. (PAZ)
Change in holdings of interested parties/officers
ASHTROM GROUP LTD (ASHG)
Holdings of interested parties/officers as of 31.3.26
DANYA CEBUS LTD. (DNYA)
Holdings of interested parties/officers as of 31.3.26